Denver, Colorado 80221

  • Ankle and or Hindfoot Injury


The purpose of this randomized controlled trial is to assess the effect of DN at either the site of the identified myofascial trigger point/s (MTrP) of in the same muscle, but away from the MTrP site/s in individuals with ankle and/or hindfoot injury. Assessments will be of self-reported outcomes, self-reported pain, gait, balance, muscle stiffness, and pain pressure threshold. The secondary purpose of this study is to determine the validity of dry needling specific muscles of the lower extremity based upon needle placement, location relative to anatomical structures and accuracy of needle placement in muscle using ultrasound imaging.

Study summary:

Few studies have assessed the validity of needling muscles of the lower extremity. For muscles such as the tibialis posterior that are not easily accessible or directly palpable secondary to the deep anatomical position and due to the proximity of the tibial nerve and the posterior tibial artery within the deep compartment, examining accurate needle placement is clinically relevant. In addition, DN has been shown to be a beneficial management strategy for individuals with lower extremity condition; however, the investigators may be able to optimize these beneficial effects by performing DN on the MTrP versus other sites within the same muscle. If needling directly into the MTrP is more effective than needling away from the MTrP but into the same muscle, it is possible that the improved efficiency could help to optimize management of patients with injury to the ankle/hindfoot with less visits and potentially decreasing health care costs.


Inclusion Criteria: - Participants with a previous lower extremity injury occurring to the ankle and/or hindfoot within the previous 12 months AND - pain greater than 3 out of 10 on the numeric pain rating scale (NPRS) OR - limited weightbearing dorsiflexion range of motion of greater than 2.0 cm side-to-side difference as measured by the ankle lunge test (ALT) OR - greater than 3.5% side-to-side difference as assessed by the Y-balance test. Exclusion Criteria: - Operative fixation within the past 3 months to the lower extremity - Have received DN of the lower extremity within the past 30 days - Current pregnancy - Have a history of systemic disorders in which DN would be contraindicated (bleeding disorders or current anticoagulant medication use) - Immunocompromised - Decline participation



Primary Contact:

Principal Investigator
Stephanie Albin
Regis University

Stephanie Albin
Phone: 303-964-6501

Backup Contact:

Larisa Hoffman
Phone: 303-964-5203

Location Contact:

Denver, Colorado 80221
United States

Stephanie Albin, PhD
Phone: 303-964-6501

Site Status: Recruiting

Data Source:

Date Processed: September 28, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.